RU92004336A - Водорастворимые производные камптотецина, способ их получения, фармацевтическая композиция, способ ингибирования энзима топоизомеразы, промежуточные продукты - Google Patents
Водорастворимые производные камптотецина, способ их получения, фармацевтическая композиция, способ ингибирования энзима топоизомеразы, промежуточные продуктыInfo
- Publication number
- RU92004336A RU92004336A RU92004336/04A RU92004336A RU92004336A RU 92004336 A RU92004336 A RU 92004336A RU 92004336/04 A RU92004336/04 A RU 92004336/04A RU 92004336 A RU92004336 A RU 92004336A RU 92004336 A RU92004336 A RU 92004336A
- Authority
- RU
- Russia
- Prior art keywords
- lower alkyl
- cycloalkyl
- alkyl
- alkoxy
- hydrogen
- Prior art date
Links
- 230000002401 inhibitory effect Effects 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 claims 25
- 125000003545 alkoxy group Chemical group 0.000 claims 8
- 125000000753 cycloalkyl group Chemical group 0.000 claims 6
- 229910052739 hydrogen Inorganic materials 0.000 claims 5
- 239000001257 hydrogen Substances 0.000 claims 5
- 125000004435 hydrogen atoms Chemical class [H]* 0.000 claims 5
- 125000003118 aryl group Chemical group 0.000 claims 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 4
- 125000003342 alkenyl group Chemical group 0.000 claims 3
- 125000001424 substituent group Chemical group 0.000 claims 2
- VSJKWCGYPAHWDS-FQEVSTJZSA-N Camptothecin Chemical class C1=CC=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 VSJKWCGYPAHWDS-FQEVSTJZSA-N 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 125000003282 alkyl amino group Chemical group 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- 125000000623 heterocyclic group Chemical group 0.000 claims 1
- -1 nitro, amino Chemical group 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 150000002829 nitrogen Chemical group 0.000 claims 1
- 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
Claims (1)
- Настоящее изобретение относится к водорастворимым производным камптотецина, описываемых формулой /I/:
где n представляет собой целое число 1 или 2; I) R1 и R2, взятые отдельно, представляют водород, низший алкил, (С3 - 7)циклоалкил, (С3 - 7)циклоалкил низший алкил, низший алкенил, окси низший алкил, низший алкокси низший алкил; 2) R1 представляет водород, низший алкил, (С3 - 7)циклоалкил, (С3 - 7)циклоалкил низший алкил, низший алкенил, окси низший алкил или низший алкокси низший алкил; R2 представляет -СОR3, где R3 представляет водород, низший алкил, пергало-низший алкил, (С3 - 7)циклоалкил, (С3 - 7)циклоалкил низший алкил, низший алкенил, окси низший алкил, низший алкокси, низший алкокси низший алкил; 3) R1 и R2, взятые вместе с соединительным атомом азота, образуют насыщенную 3-7-атомную гетероцикличную группу формулы, где
Y представляет 0, S, СН2, NR4, R4 представляет водород , низший алкил, пергало-низший алкил, арил, арил, замещенный одним или несколькими заместителями, выбранными из группы, включающей низший алкил, галоген, нитро, амино, низший алкил амино, пергало-низший алкил, окси низший алкил, низший алкокси, низший алкокси низший алкил или -СОR5, где R5 представляет водород, низший алкил, пергало-низший алкил, низший алкокси, арил, арил, замещенный одним или несколькими заместителями, выбранными из группы, включающей: низший алкил, пергало-низший алкил, окси низший алкил, низший алкокси низший алкил. Также предложены их фармацевтически приемлемые соли, их применение для лечения опухолей и методы приготовления.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US78427591A | 1991-10-29 | 1991-10-29 | |
US07/784275 | 1991-10-29 | ||
US82672992A | 1992-01-28 | 1992-01-28 | |
US07/826729 | 1992-01-28 |
Publications (2)
Publication Number | Publication Date |
---|---|
RU92004336A true RU92004336A (ru) | 1995-08-20 |
RU2119921C1 RU2119921C1 (ru) | 1998-10-10 |
Family
ID=27120258
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU92004336A RU2119921C1 (ru) | 1991-10-29 | 1992-10-28 | Производные камптотецина, способы их получения, соединения, фармацевтическая композиция |
Country Status (25)
Country | Link |
---|---|
EP (1) | EP0540099B1 (ru) |
JP (2) | JP3020760B2 (ru) |
KR (1) | KR100246154B1 (ru) |
CN (1) | CN1072683A (ru) |
AP (1) | AP306A (ru) |
AT (1) | ATE136898T1 (ru) |
AU (1) | AU657007B2 (ru) |
CA (1) | CA2081580A1 (ru) |
CZ (1) | CZ284023B6 (ru) |
DE (1) | DE69209969T2 (ru) |
DK (1) | DK0540099T3 (ru) |
ES (1) | ES2086643T3 (ru) |
FI (3) | FI104373B (ru) |
GR (1) | GR3020120T3 (ru) |
HU (2) | HU217970B (ru) |
IL (1) | IL103571A (ru) |
IS (1) | IS1708B (ru) |
MX (1) | MX9206211A (ru) |
MY (1) | MY108261A (ru) |
NO (1) | NO302073B1 (ru) |
NZ (1) | NZ244914A (ru) |
OA (1) | OA09767A (ru) |
RU (1) | RU2119921C1 (ru) |
SK (1) | SK279298B6 (ru) |
TW (1) | TW221994B (ru) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5364858A (en) * | 1987-03-31 | 1994-11-15 | Research Triangle Institute | Camptothecin analogs as potent inhibitors of topoisomerase I |
US5552154A (en) | 1989-11-06 | 1996-09-03 | The Stehlin Foundation For Cancer Research | Method for treating cancer with water-insoluble s-camptothecin of the closed lactone ring form and derivatives thereof |
US6080751A (en) * | 1992-01-14 | 2000-06-27 | The Stehlin Foundation For Cancer Research | Method for treating pancreatic cancer in humans with water-insoluble S-camptothecin of the closed lactone ring form and derivatives thereof |
AP9300587A0 (en) * | 1992-11-12 | 1995-05-05 | Glaxo Inc | Water soluble camptothecin derivatives. |
DE69435084T2 (de) * | 1993-01-15 | 2009-03-19 | The Stehlin Foundation For Cancer Research, Houston | Die Verwendung von wasserunlöslichem S-Camptothecin mit geschlossenem Lactonring für die Herstellung eines Medikamentes zur Behandlung von Darmkrebs |
US5369127A (en) * | 1993-04-21 | 1994-11-29 | Allergan, Inc. | 1,3-benzodioxole and 1,2-dialkoxybenzene derivatives as ocular hypotensive agents |
IS4152A (is) * | 1993-04-29 | 1994-10-30 | Glaxo Inc. | Vatnsuppleysanlegar Camptothecin afleiður og aðferð til framleiðslu þeirra |
JPH08509742A (ja) * | 1993-05-03 | 1996-10-15 | スミスクライン・ビーチャム・コーポレイション | 置換メチレンジオキシ[3’,4’:6,7]インドリジノ[1,2−b]キノリノン |
US5447936A (en) * | 1993-12-22 | 1995-09-05 | Bionumerik Pharmaceuticals, Inc. | Lactone stable formulation of 10-hydroxy 7-ethyl camptothecin and methods for uses thereof |
US5491237A (en) * | 1994-05-03 | 1996-02-13 | Glaxo Wellcome Inc. | Intermediates in pharmaceutical camptothecin preparation |
IT1269862B (it) * | 1994-05-30 | 1997-04-15 | Indena Spa | Alcaloidi da mappia foetida, loro uso e formulazioni che li contengono |
US5646159A (en) * | 1994-07-20 | 1997-07-08 | Research Triangle Institute | Water-soluble esters of camptothecin compounds |
KR960029336A (ko) | 1995-01-09 | 1996-08-17 | 김충환 | 캄토테신 유도체, 그의 제조 방법 및 이를 함유하는 항암제 |
US5496952A (en) * | 1995-02-07 | 1996-03-05 | North Carolina State University | Method of making asymmetric DE ring intermediates for the synthesis of camptothecin and camptothecin analogs |
US5670500A (en) * | 1995-05-31 | 1997-09-23 | Smithkline Beecham Corporation | Water soluble camptothecin analogs |
ATE275132T1 (de) * | 1995-06-27 | 2004-09-15 | Takeda Chemical Industries Ltd | 4-acylamino(halogen)alkyl-chinolin derivate, deren herstellung und deren verwendung als melatonin-agonisten |
SG50747A1 (en) * | 1995-08-02 | 1998-07-20 | Tanabe Seiyaku Co | Comptothecin derivatives |
AU7732996A (en) * | 1995-11-22 | 1997-06-11 | Research Triangle Institute | Camptothecin compounds with combined topoisomerase i inhibition and dna alkylation properties |
CA2192725C (en) | 1995-12-28 | 2004-04-20 | Kenji Tsujihara | Camptothecin derivatives |
SG88737A1 (en) | 1996-10-30 | 2002-05-21 | Tanabe Seiyaku Co | S type 2-substituted hydroxy-2-indolidinylbutyric ester compounds and process for preparation thereof |
US6559309B2 (en) | 1996-11-01 | 2003-05-06 | Osi Pharmaceuticals, Inc. | Preparation of a camptothecin derivative by intramolecular cyclisation |
US6207673B1 (en) | 1997-03-12 | 2001-03-27 | The University Of North Carolina At Chapel Hill | Covalent conjugates of topoisomerase I and topoisomerase II inhibitors |
US6046209A (en) * | 1997-05-27 | 2000-04-04 | Smithkline Beecham Corporation | Water soluble camptothecin analogs |
US6288072B1 (en) * | 1999-12-29 | 2001-09-11 | Monroe E. Wall | Camptothecin β-alanine esters with topoisomerase I inhibition |
CA2401191C (en) | 2000-02-28 | 2006-05-02 | Aventis Pharma S.A. | A composition comprising camptothecin and a pyrimidine derivative for the treatment of cancer |
US6548488B2 (en) | 2000-03-17 | 2003-04-15 | Aventis Pharma S.A. | Composition comprising camptothecin or a camptothecin derivative and an alkylating agent for the treatment of cancer |
US6545010B2 (en) | 2000-03-17 | 2003-04-08 | Aventis Pharma S.A. | Composition comprising camptothecin or a camptothecin derivative and a platin derivative for the treatment of cancer |
US6486320B2 (en) | 2000-09-15 | 2002-11-26 | Aventis Pharma S.A. | Preparation of camptothecin and of its derivatives |
NZ524855A (en) | 2000-10-27 | 2004-10-29 | Aventis Pharma S | A combination comprising camptothecin and a stilbene derivative preferably combrestatin for the treatment of cancer |
ITRM20040240A1 (it) * | 2004-05-13 | 2004-08-13 | Ist Naz Stud Cura Dei Tumori | Camptotecine coniugate in posizione 7 con antagonisti delle integrine. |
WO2006069344A2 (en) | 2004-12-22 | 2006-06-29 | Rutgers, The State University Of New Jersey | Controlled release hydrogels |
CA2658015A1 (en) | 2006-03-30 | 2007-10-11 | Diatos S.A. | Camptothecin-peptide conjugates and pharmaceutical compositions containing the same |
CN101407524B (zh) * | 2007-10-09 | 2012-07-18 | 江苏先声药物研究有限公司 | 噁嗪骈喜树碱衍生物及其制备方法和用途 |
CN100592871C (zh) * | 2008-03-14 | 2010-03-03 | 浙江林学院 | 一种杀虫剂组合物及其加工方法 |
ES2373172B1 (es) * | 2010-07-16 | 2012-12-10 | Consejo Superior De Investigaciones Científicas (Csic) | Proceso de obtención de derivados solubles en agua de 20 (s) camptotecina como agentes antitumorales. |
US20140086975A1 (en) | 2010-10-15 | 2014-03-27 | Rutgers, The State University Of New Jersey | Hydrogel formulation for dermal and ocular delivery |
WO2012096832A2 (en) * | 2011-01-12 | 2012-07-19 | Crystal Biopharmaceutical Llc | Hdac inhibiting derivatives of camptothecin |
US20190343828A1 (en) * | 2018-04-06 | 2019-11-14 | Seattle Genetics, Inc. | Camptothecin peptide conjugates |
CN110590796B (zh) * | 2018-06-12 | 2022-07-15 | 青岛海洋生物医药研究院股份有限公司 | 喜树碱衍生物及其制备方法和应用 |
AU2022330892A1 (en) * | 2021-08-19 | 2024-03-21 | Simcere Zaiming Pharmaceutical Co., Ltd. | Camptothecin derivative, and pharmaceutical composition and use thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5004758A (en) * | 1987-12-01 | 1991-04-02 | Smithkline Beecham Corporation | Water soluble camptothecin analogs useful for inhibiting the growth of animal tumor cells |
-
1992
- 1992-10-23 EP EP92203263A patent/EP0540099B1/en not_active Expired - Lifetime
- 1992-10-23 ES ES92203263T patent/ES2086643T3/es not_active Expired - Lifetime
- 1992-10-23 DK DK92203263.6T patent/DK0540099T3/da active
- 1992-10-23 AT AT92203263T patent/ATE136898T1/de not_active IP Right Cessation
- 1992-10-23 DE DE69209969T patent/DE69209969T2/de not_active Expired - Fee Related
- 1992-10-27 SK SK3237-92A patent/SK279298B6/sk unknown
- 1992-10-27 TW TW081108539A patent/TW221994B/zh active
- 1992-10-27 CZ CS923237A patent/CZ284023B6/cs not_active IP Right Cessation
- 1992-10-28 AP APAP/P/1992/000439A patent/AP306A/en active
- 1992-10-28 IS IS3936A patent/IS1708B/is unknown
- 1992-10-28 OA OA60295A patent/OA09767A/en unknown
- 1992-10-28 NO NO924158A patent/NO302073B1/no unknown
- 1992-10-28 JP JP4312862A patent/JP3020760B2/ja not_active Expired - Fee Related
- 1992-10-28 NZ NZ244914A patent/NZ244914A/xx not_active IP Right Cessation
- 1992-10-28 KR KR1019920019884A patent/KR100246154B1/ko not_active IP Right Cessation
- 1992-10-28 MY MYPI92001954A patent/MY108261A/en unknown
- 1992-10-28 IL IL103571A patent/IL103571A/en not_active IP Right Cessation
- 1992-10-28 HU HU9203384A patent/HU217970B/hu not_active IP Right Cessation
- 1992-10-28 AU AU27385/92A patent/AU657007B2/en not_active Ceased
- 1992-10-28 CA CA002081580A patent/CA2081580A1/en not_active Abandoned
- 1992-10-28 FI FI924878A patent/FI104373B/fi active
- 1992-10-28 CN CN92113782A patent/CN1072683A/zh not_active Withdrawn
- 1992-10-28 RU RU92004336A patent/RU2119921C1/ru not_active IP Right Cessation
- 1992-10-28 MX MX9206211A patent/MX9206211A/es unknown
-
1995
- 1995-06-14 HU HU95P/P00203P patent/HU211349A9/hu unknown
-
1996
- 1996-05-31 GR GR960401497T patent/GR3020120T3/el unknown
-
1998
- 1998-10-08 FI FI982185A patent/FI982185A/fi unknown
-
1999
- 1999-11-02 JP JP31294099A patent/JP3229298B2/ja not_active Expired - Fee Related
-
2002
- 2002-06-07 FI FI20021090A patent/FI20021090A/fi not_active Application Discontinuation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU92004336A (ru) | Водорастворимые производные камптотецина, способ их получения, фармацевтическая композиция, способ ингибирования энзима топоизомеразы, промежуточные продукты | |
ES2173074T3 (es) | Derivados de xantina, procedimiento para su preparacion y su uso farmaceutico. | |
DK34793A (da) | Vandoploeseligt, farmaceutisk acceptabelt salt af et monoacylderivat af rapamycin, fremgangsmaade til dets fremstilling og injicerbart, farmaceutisk praeparat indeholdende det | |
NO167741C (no) | Analogifremgangsmaate for fremstilling av terapeutiske rebeccamycinanaloger. | |
DE68906552T2 (de) | Camptothecin-Derivate und Verfahren zu ihrer Herstellung. | |
MY101359A (en) | 7-acylamino-3-vinylcephalosporanic acid derivatives, processes for their preparation, pharmaceutical compositions containing them, their starting compounds and their preparation | |
DK0590919T3 (da) | Terapeutiske midler mod Parkinsons sygdom | |
KR960701878A (ko) | 수용성 캄프토테신 유도체, 이의 제조 방법 및 항종양제로서의 이의 용도(Water-soluble camptothecin derivatives, process for their preparation and their use as antitumor agents) | |
DK1063228T5 (da) | Cycloalkenderivater, fremgangsmåde til fremstilling deraf og anvendelse deraf | |
ES2112386T3 (es) | Agentes terapeuticos para uso en el tratamiento de la enfermedad de parkinson. | |
SE0101579D0 (sv) | New compounds | |
KR910007883A (ko) | 퀴놀린 유도체, 그의 제조방법 및 용도 | |
YU46706B (sh) | Postupak za dobijanje amidnih jedinjenja | |
DK196688D0 (da) | Bicykliske forbindelser og fremgangsmaade til fremstilling deraf | |
RU99115829A (ru) | Новые аналоги камптотецина, их применение в качестве лекарственных средств и содержащие их фармацевтические композиции | |
RU99109978A (ru) | Бис(акридинкарбоксамид) и бис(феназинкарбоксамид), полезные в качестве противоопухолевых агентов | |
RU99113432A (ru) | Новые производные фенантридиния | |
GB1469197A (en) | Preparation of 1-aminoalkyl triazolobenzodiazepines | |
KR960004338A (ko) | 신규한 7-아미노옥시피롤리딘 퀴놀린 카르복실산 유도체 및 그의 제조방법 | |
RU99115884A (ru) | Пролекарственные формы и новые аналоги камптотецина, их применение в качестве лекарственных средств | |
KR940003920A (ko) | 테트라히드로나프탈렌 유도체, 이것의 제법 및 이것의 치료에의 이용 | |
NO903084L (no) | Farmasoeytisk anvendbare thiazolderivater og fremgangsmaatefor deresfremstilling. | |
RU2005105329A (ru) | Общий синтез мериапоронов | |
RU93041059A (ru) | 1-азабициклоалкан производные, фармацевтические композиции, их содержащие, и способ их получения | |
FR2633292B1 (fr) | Nouveaux derives de la 20,21-dinoreburnamenine substitues en 15 par un groupement amine, leur procede de preparation et les intermediaires ainsi obtenus, leur application comme medicaments et les compositions pharmaceutiques les reenfermant |